维普中文期刊产品整合服务
879篇 您的检索式:作者名="Brien F"
    题名 作者 年代 出处 被引量
1血管性认知障碍的诊断标准:国际血管性行为与认知障碍学会的申明显示文摘长期以来,脑血管病(CVD)就被认为是认知损害的一个重要原因,但是有关脑血管病后认知障碍的概念化却有着一段多变的历史。'动脉变硬'或脑的动脉粥样硬化是'老化'的原因,是存在已久的观点,在20世纪60年代受到了来自英格兰纽卡斯尔的神经病理学研究的质疑。这些研究表明,血管性痴呆(vascular dementia,Va D)与超过一定程度的多发性脑梗死有关。徐岩 郭起浩 Sachdev P Kalaria R O'Brien J Skoog I Alladi S Black SE Blacker D Blazer DG Chen C Chui H Ganguli M Jellinger K Jeste DV Pasquier F Paulsen J Prins N Rockwood K Roman G Scheltens P 2014神经病学与神经康复学杂志2014,11,3:19
2人参减少 γ射线照射的淋巴细胞微核量(英文)显示文摘目的 评价中国人参对减少辐射诱导的人周围血 G0 期淋巴细胞 (PBL)微核量的作用。方法 采用细胞因子阻滞的微核法检测健康志愿者的血标本。体外 1 37Cs照射之前 ,每份血标本的单个核细胞培养以不同浓度 (0~ 2 0 0 0μg· m l- 1 )的人参根水提取物孵育 2 4 h。结果 (1)在 0 Gy时 ,每 10 0 0个双核 (BN )细胞的微核量是 11.3± 2 .7,人参水提取物≥ 5 0 0μg· ml- 1 时微核量下降 ,但微核量和人参水提取物的浓度之间的差异是显著的。 (2 )单独射线照射显著增加微核量 ,当暴露于 1Gy的照射时 ,随着培养介质中人参水提取物浓度的增加 ,微核量呈显著的线性降低 (R2 =0 .0 5 ,P =0 .0 0 2 ) ;对暴露于 1Gy辐射诱导的微核量 ,人参水提取物浓度在 15 0 0μg· m l- 1 时减少 4 6 .6 % ,浓度在 2 0 0 0μg·m l- 1时减少 5 7.6 % ;对暴露于 2 Gy辐射诱导的微核量的减少呈更强的线性相关 (R2 =0 .7,P=0 .0 0 0 1) ;(3)微核数据分析的结果呈现出与 Poisson模型相关的过度离散趋势。结果表明 :(1)人参水提取物浓度达 2 0 0 0 μg· ml- 1时 ,对 PBL 细胞毒作用无明显影响 ;(2 )人参水提取物浓度在 5 0 0 μg· ml- 1和 2 0 0 0 μg· ml- 1之间时 ,对抗 1 37Cs照射诱导的 MN发挥保护作用。李同光 Ron R Allison Kevin F O'Brien Prabhaker G Khazanie Larry J Dobbs Jr. Peter J Kragel 2004新乡医学院学报2004,21,3:3
3Pedicle Morphology In Thoracic Adolescent Idiopathic Scoliosis: Is Pedicle Fixation an Anatomically Viable Technique?显示文摘Michael F O’Brien Lawrence G Lenke Steven Mardjetko Thomas G Lowe Yinong Kong Kevin Eck David Smith 2000Spine2000,,18:2
4Thermal self-sustainability of biochar production by pyrolysis显示文摘Berruti F Briens C 2011Journal of Analytical and Applied Pyrolysis2011,91,1:1
5Production of antibodies to Staphylococcus aureus serotype 5,8 and 336 using poly(DL-lactide-co-glycoli-de)microspheres显示文摘O′Brien C N Guidry A J attom A F 2000J Dairy Sci2000,83,:1
6High efficient phosphorescent emission from organic electroluminescent diodes 显示文摘Baldo M A O'brien D F 1998Nature1998,395,:1
7Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System显示文摘Kantarjian H O'Brien S Ravandi F 0,,:1
8Influence of freezing rate on pore structure in freeze-dried collagen-GAG scafflolds 显示文摘Brien F J Harley B A Yamtas I V 2004Biomaterials2004,25,6:1
9Highly efficient phosphorescent emission from organic electroluminescent devices 显示文摘Baldo M A O′Brien D F You Y 1998Nature1998,395,10:1
10Highly efficient phosphorescent emission from organic electroluminescence devices显示文摘Baldo M A O'Brien D F You Y Shoustikov A Sibley S Thompson M E Forret S R 0,,:1
11Improving knowledge, attitudes and beliefs about acute coronary syndrome through an individualized educational intervention: A randomized con- trolled trial显示文摘O ~ Brien F McKee G Mooney M 2014Pat edu and coun2014,96,2:1
12Intensive chemotherapy does not benefit most older patients( age 70 years or older)with acute myeloid leukemia显示文摘Kantariian H Ravandi F O'Brien S 2010Blood2010,116,22:1
13Cardiostimulant effect of urotensinⅡ in human heart in vitro显示文摘Russell F D Molenaar P O' Brien D M 2001Br J Pharmacol2001,132,:1
14Ediaearan biota on Bonavista Peninsula, Newfoundland, Canada显示文摘Hofmann H J O'Brien S J King A F 2008Journal of Paleontology2008,82,1:1
15Highly efficient phosphorescent emission from organic electroluminescent devices 显示文摘BALDO M A O'BRIEN D F YOU Y 1998Nature1998,395,:1
16Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia显示文摘O'Brien S G Guilhot F Larson R A New England Journal of Medicine0,,:1
17Improving access to analgesic drugs for patients with cancer in sub-saharan Africa显示文摘O'Brien M Mwangi-Powell F Adewole IF 2013Lancet Oncol2013,14,4:1
18The Synergraft valve:A new acellular(nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation显示文摘 Goldstein S Walsh S 1999Semin Thora Cardiovasc Surg1999,111,41:1
19Spheroidization of mediumcarbon steel 显示文摘O’ Brien J M Hosford W F 1997Journal of Materials Engineering andPerformance1997,6,1:1
20Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia显示文摘Druker BJ Guilhot F O'Brien SG 0,,:1
返回顶部 每页显示:
共44页 首页 上一页 第1页 下一页 末页 /44 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费